In Other News

• Researchers Use Virtual Screening and Cell-Based Assays to Identify Repurposed Drugs for COVID-19 Treatment

• CT Scans Prove Highly Accurate in Diagnosing COVID-19 Pneumonia and Predicting Death or Need for Intubation

• Machine Learning Algorithm Trained on Images of Everyday Items Detects COVID-19 in Chest X-Rays with 99% Accuracy

• COVID-19 Patients Recover Faster with Metabolic Activator Treatment, Study Shows

• Face Mask with Wearable Biosensors Accurately Diagnoses COVID-19 Within 90 Minutes

• Oxford University to Study Wonder Drug Ivermectin as Possible Treatment for COVID-19

• Roche’s Actemra Granted US FDA Emergency Use Authorization for Treatment of Hospitalized COVID-19 Patients

• Medical AI Models Rely on 'Shortcuts' That Could Lead to Misdiagnosis of COVID-19

• Monoclonal Antibody Therapy Reduces Hospitalizations When Given Early to Patients at High Risk for Severe COVID-19

• Fujitsu to Detect and Analyze New COVID-19 Drugs by Leveraging World’s Fastest Supercomputer

• COVID-19 Dual-Antibody Therapies Found Effective Against SARS-CoV-2 Variants in Animal Study

• New Immunotherapy Platform Deploys Engineered Molecules to Inhibit SARS-CoV-2 Infection and Remove COVID-19 Infected Cells

• Lung Ultrasound Used to Manage Critically Ill COVID-19 Patients Leads to Huge Time Savings as Compared to Chest CT

• Gilead’s Remdesivir Reduced Mortality in Hospitalized COVID-19 Patients, Shows Real-World Data Analyses

• Tapeworm Drug Niclosamide Shows Strong Antiviral Effect as Potential New Treatment for COVID-19

• PET Imaging Can Accurately Measure Cognitive Impairment in COVID-19 Patients

• First-in-Class Nasal Spray Could Both Treat and Prevent COVID-19

• AI-Enhanced EKG Can Be Used as Rapid, Reliable COVID-19 Screening Test to Rule out Infection

• Getinge's AI Solution Helps Hospitals Address Post COVID-19 Pandemic Surgical Backlog

• Oral COVID-19 Vaccine Proves an Effective Booster in Preclinical Trial

• Engineered IgM Antibody Administered Intranasally May Be More Potent at Inhibiting SARS-CoV-2 and Its Variants than Current Antibody Therapies

• Experimental Drug TEMPOL May Be Promising Oral Antiviral Treatment for COVID-19, Suggests New Research

• Next-Generation COVID-19 Antibody to Neutralize SARS-CoV-2 Mutated Variants and Allow Injectable Dosing